Published in J Virol on July 01, 2006
HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneck. Science (2014) 2.38
Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression. J Virol (2007) 1.98
HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection. J Virol (2008) 1.13
A signature in HIV-1 envelope leader peptide associated with transition from acute to chronic infection impacts envelope processing and infectivity. PLoS One (2011) 1.03
CD4+ target cell availability determines the dynamics of immune escape and reversion in vivo. J Virol (2008) 1.00
Maintenance of Nef-mediated modulation of major histocompatibility complex class I and CD4 after sexual transmission of human immunodeficiency virus type 1. J Virol (2007) 0.95
Phylogenetic analysis consistent with a clinical history of sexual transmission of HIV-1 from a single donor reveals transmission of highly distinct variants. Retrovirology (2011) 0.89
Immune-mediated attenuation of HIV-1. Future Virol (2011) 0.89
Efficient repeated low-dose intravaginal infection with X4 and R5 SHIVs in rhesus macaque: implications for HIV-1 transmission in humans. Virology (2007) 0.87
High viral fitness during acute HIV-1 infection. PLoS One (2010) 0.82
Integrating genealogical and dynamical modelling to infer escape and reversion rates in HIV epitopes. Proc Biol Sci (2013) 0.80
Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection. AIDS (2017) 0.77
Exceptional Heterogeneity in Viral Evolutionary Dynamics Characterises Chronic Hepatitis C Virus Infection. PLoS Pathog (2016) 0.76
Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science (1993) 13.87
Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature (1991) 10.85
HIV evolution: CTL escape mutation and reversion after transmission. Nat Med (2004) 10.21
Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature (2000) 9.80
Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature (2004) 9.53
Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science (2002) 9.17
Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science (2004) 8.60
Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci U S A (1997) 8.05
Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science (1992) 7.44
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature (2002) 7.41
Evolution and transmission of stable CTL escape mutations in HIV infection. Nature (2001) 6.57
Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol (1993) 6.41
Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat Med (2004) 6.33
Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J Virol (2004) 4.20
HLA and AIDS: a cautionary tale. Trends Mol Med (2001) 3.51
Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population. J Infect Dis (2003) 2.54
Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes. J Exp Med (2003) 2.17
Simian-human immunodeficiency virus escape from cytotoxic T-lymphocyte recognition at a structurally constrained epitope. J Virol (2003) 2.15
A prospective trial of structured treatment interruptions in human immunodeficiency virus infection. Arch Intern Med (2003) 1.44
HIV/AIDS. HLA leaves its footprints on HIV. Science (2002) 1.39
Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes. J Virol (2005) 1.21
Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1. J Clin Invest (1997) 1.21
Diminished representation of HIV-1 variants containing select drug resistance-conferring mutations in primary HIV-1 infection. J Acquir Immune Defic Syndr (2004) 1.19
Sexual transmission of single human immunodeficiency virus type 1 virions encoding highly polymorphic multisite cytotoxic T-lymphocyte escape variants. J Virol (2005) 1.10
Predicting the transmission of drug-resistant HIV: comparing theory with data. Lancet Infect Dis (2003) 1.07
Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides. Hum Immunol (2003) 1.07
Rapid full-length genomic sequencing of two cytopathically heterogeneous Australian primary HIV-1 isolates. J Biomed Sci (2000) 0.92
DNA HLA-DRB1 analysis in children of positive mothers and estimated risk of vertical HIV transmission. Dis Markers (1993) 0.89
Susceptibility to HIV infection and AIDS in Italian haemophiliacs is HLA associated. Br J Haematol (1990) 0.88
HLA disease association and protection in HIV infection among African Americans and Caucasians. Pathobiology (1991) 0.85
Genetic risk factors for perinatally acquired HIV-1 infection. Paediatr Perinat Epidemiol (1992) 0.82
Phenotypic analysis of antigen-specific T lymphocytes. Science (1996) 24.26
Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med (1997) 12.26
HIV evolution: CTL escape mutation and reversion after transmission. Nat Med (2004) 10.21
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol (1993) 8.07
Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci U S A (1997) 8.05
Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. Proc Natl Acad Sci U S A (2001) 7.90
Immune control of HIV-1 after early treatment of acute infection. Nature (2000) 7.68
HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA (1989) 6.68
Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med (2001) 6.51
Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol (1993) 6.41
The Neutron Pile as a Tool in Quantitative Analysis; The Gallium and Palladium Content of Iron Meteorites. Science (1949) 6.35
The epidemic behavior of the hepatitis C virus. Science (2001) 4.81
Compilation of tRNA sequences and sequences of tRNA genes. Nucleic Acids Res (1989) 4.79
The initiation sites for RNA transcription in Ad2 DNA. Cell (1977) 4.76
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med (1998) 4.65
Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol (1996) 4.43
Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med (2001) 4.42
The definition of a large viral transcription unit late in Ad2 infection of HeLa cells: mapping by effects of ultraviolet irradiation. Cell (1977) 4.13
Is clearance of HIV-1 viraemia at seroconversion mediated by neutralising antibodies? Lancet (1992) 4.05
Case-control study of sudden infant death syndrome in Scotland, 1992-5. BMJ (1997) 4.03
The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? AIDS Res Hum Retroviruses (1991) 3.78
Evolutionary aspects of recombination in RNA viruses. J Gen Virol (1999) 3.74
Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol (1993) 3.73
Population dynamics of flaviviruses revealed by molecular phylogenies. Proc Natl Acad Sci U S A (1996) 3.69
Organization of intrahippocampal projections originating from CA3 pyramidal cells in the rat. J Comp Neurol (1990) 3.67
Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes. Proc Natl Acad Sci U S A (2000) 3.66
Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature (1995) 3.61
Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery (1968) 3.56
Extinction rates can be estimated from molecular phylogenies. Philos Trans R Soc Lond B Biol Sci (1994) 3.47
Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A (2000) 3.44
Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest (1997) 3.39
Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol (1992) 3.37
Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci U S A (1998) 3.35
The definition of a large viral transcription unit late in Ad2 infection of HeLa cells: mapping of nascent RNA molecules labeled in isolated nuclei. Cell (1977) 3.32
Voltage-clamp investigations of membrane currents underlying pace-maker activity in rabbit sino-atrial node. J Physiol (1980) 3.30
International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA. Lancet (1990) 3.29
Computer support for interpreting family histories of breast and ovarian cancer in primary care: comparative study with simulated cases. BMJ (2000) 3.12
Pathogenicity of Helicobacter pylori: a perspective. Infect Immun (1993) 3.08
Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. AIDS Res Hum Retroviruses (1996) 3.01
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation (2000) 2.95
Cattle as a possible source of verocytotoxin-producing Escherichia coli O157 infections in man. Epidemiol Infect (1993) 2.94
Validation of questionnaire and bronchial hyperresponsiveness against respiratory physician assessment in the diagnosis of asthma. Int J Epidemiol (1996) 2.91
Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A (1998) 2.88
Genetic analysis of adenovirus type 2 III. Temperature sensitivity of processing viral proteins. J Virol (1976) 2.88
Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol (1993) 2.87
Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A (1998) 2.86
Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc Natl Acad Sci U S A (2006) 2.77
HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS. Am J Pathol (1986) 2.77
Carcinoid tumor metastatic to the breast. Arch Surg (1998) 2.71
Enhanced cellulase production by a mutant of Trichoderma viride. Appl Microbiol (1971) 2.67
Evaluation of computer support for prescribing (CAPSULE) using simulated cases. BMJ (1997) 2.61
Mortality and complications associated with laparoscopic cholecystectomy. A meta-analysis. Ann Surg (1996) 2.56
Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period. Virology (2002) 2.53
Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol (1994) 2.53
Ecology and evolution of rabies virus in Europe. J Gen Virol (1999) 2.52
Escape of human immunodeficiency virus from immune control. Annu Rev Immunol (1997) 2.52
Ultrastructure of the gastric mucosa harboring Campylobacter-like organisms. Am J Clin Pathol (1986) 2.52
Causes of HIV diversity. Nature (1995) 2.48
Voluntary regionalization and associated trends in perinatal care: the Nova Scotia Reproductive Care Program. Am J Obstet Gynecol (1983) 2.45
The role of the adenovirus protease on virus entry into cells. EMBO J (1996) 2.44
Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J Rheumatol (1994) 2.43
Human foamy virus reverse transcription that occurs late in the viral replication cycle. J Virol (1997) 2.42
Sacral insufficiency fractures: an unsuspected cause of low back pain. Br J Rheumatol (1998) 2.41
Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 2.41
Bacteriological studies of the venom and mouth cavities of wild Malayan pit vipers (Calloselasma rhodostoma) in southern Thailand. Trans R Soc Trop Med Hyg (1991) 2.38
Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer (1990) 2.32
No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet (1998) 2.32
Hypoglycemia during diarrhea in childhood. Prevalence, pathophysiology, and outcome. N Engl J Med (1990) 2.30
Validity of Euroqol--a generic health status instrument--in patients with rheumatoid arthritis. Economic and Health Outcomes Research Group. Br J Rheumatol (1994) 2.27
Breast cancer surgery without suction drainage: the impact of adopting a 'no drains' policy on symptomatic seroma formation rates. Eur J Surg Oncol (2013) 2.24
Hypoglycaemia in paediatric admissions in Mozambique. Lancet (1994) 2.23
Risky business: health and safety in the sex industry over a 9 year period. Sex Transm Infect (1999) 2.22
Inferring population history from molecular phylogenies. Philos Trans R Soc Lond B Biol Sci (1995) 2.21
Movement of motor and cargo along cilia. Nature (1999) 2.21
Human immunodeficiency virus. Phylogeny and the origin of HIV-1. Nature (2001) 2.20
A likelihood method for the detection of selection and recombination using nucleotide sequences. Mol Biol Evol (1997) 2.20
Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. J Infect Dis (1986) 2.18
Investigation of potential HIV transmission to the patients of an HIV-infected surgeon. JAMA (1993) 2.17
Use of the polymerase chain reaction to detect DNA sequences specific to pathogenic treponemes in cerebrospinal fluid. FEMS Microbiol Lett (1990) 2.17
Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology (1998) 2.15
Prevalence of HIV infection in patients attending an inner city accident and emergency department. BMJ (1994) 2.15
BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg (1974) 2.14
Oligoclonal expansions of CD8(+) T cells in chronic HIV infection are antigen specific. J Exp Med (1998) 2.13
P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site. J Biol Chem (1995) 2.12
Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies. N Engl J Med (1985) 2.12
Widespread intra-serotype recombination in natural populations of dengue virus. Proc Natl Acad Sci U S A (1999) 2.12
Networks and groups within the genus Neisseria: analysis of argF, recA, rho, and 16S rRNA sequences from human Neisseria species. Mol Biol Evol (1999) 2.10
Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles. Arthritis Rheum (2007) 2.10
The role of MCM proteins in the cell cycle control of genome duplication. Bioessays (1996) 2.09
A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE). Health Technol Assess (2013) 2.09
Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J Immunol (1994) 2.07
The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial. J Thorac Cardiovasc Surg (1991) 2.06
British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Med (2012) 2.05
Cross-reaction of immune sera from patients with rickettsial diseases. J Med Microbiol (1989) 2.04